Healthcare Services

An Important Factor Driving the Gene Transfer Technologies Market Is the Surge In Genetic Disorders Fueling The Growth Of The Market Due To Increasing Diagnosis And Survival Rates

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Gene Transfer Technologies Market Over The 2026–2030 Period?

The market for gene transfer technologies has experienced significant expansion recently. This market is projected to expand from $4.54 billion in 2025 to $5.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.3%. Historically, this expansion has been driven by progress in molecular biology research, a rise in financial support for genetic studies, increased output of recombinant proteins, initial positive results from gene therapies, and the proliferation of academic and research institutions.

The gene transfer technologies market is projected to experience swift expansion over the coming years. This market is set to reach a valuation of $8.77 billion by 2030, showing a robust compound annual growth rate (CAGR) of 14.0%. Several factors are contributing to this anticipated growth, including a surge in demand for personalized medicine, greater investments in gene therapy development, the broadening scope of regenerative medicine uses, the increasing implementation of precision genetic engineering instruments, and enhanced partnerships between biotechnology and pharmaceutical firms. Key trends expected during this period involve a rise in the utilization of viral vector gene delivery systems, increased preference for non-viral gene transfer approaches, a heightened focus on highly efficient transfection technologies, the growth of ex vivo gene modification methods, and a stronger emphasis on platforms for scalable gene delivery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30288&type=smp

What Drivers Are Expected To Influence The Gene Transfer Technologies Market During The Forecast Period?

An increasing occurrence of genetic disorders is projected to advance the gene transfer technologies market moving forward. Genetic disorders are conditions that result from alterations in one or more genes or chromosomes, which impede normal biological function. The growing incidence of genetic disorders largely stems from improved diagnostic methods and reporting, an aging global population, and higher survival rates among affected infants due to better clinical care. Gene transfer technologies facilitate the targeted delivery and correction of defective genes, support the creation of gene therapies and precision treatments, and expand diagnostic and research capabilities. For instance, in February 2025, according to the World Health Organization, a Switzerland-based UN health agency, more than 300 million people worldwide live with rare diseases, approximately 70% of which have their onset in childhood. Therefore, the rising prevalence of genetic disorders is propelling the growth of the gene transfer technologies market.

How Is The Gene Transfer Technologies Market Segmented Across Key Categories?

The gene transfer technologies market covered in this report is segmented –

1) By Product: Reagents, Kits, And Assays, Consumables, Instruments, Other Products

2) By Vector Type: Viral, Retrovirus, Adenovirus, Adeno-Associated Virus, Non-Viral, Electroporation, Gene Gun

3) By Method: In Vivo, Ex Vivo, In Vitro

4) By Applications: Gene Therapy, Personalized Medicine, Regenerative Medicine, Vaccines Development

5) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Contract Research Organizations

Subsegments:

1) By Reagents, Kits, And Assays: Deoxyribonucleic Acid Reagents, Ribonucleic Acid Reagents, Protein Assay Kits, Cell Transfection Kits, Gene Expression Assay Kits, Reporter Gene Assays

2) By Consumables: Culture Media, Buffers And Solutions, Microplates, Pipette Tips, Tubes And Vials, Filters And Membranes

3) By Instruments: Transfection Systems, Electroporators, Gene Guns, Cell Analyzers, Micropipetting Systems, Centrifuges

4) By Other Products: Cell Lines, Plasmid DNA, Viral Vectors, Nanoparticles, Microfluidic Devices, Genetic Markers

Which Trends Are Influencing The Gene Transfer Technologies Market?

Major companies operating in the gene transfer technologies market are focusing on advanced manufacturing platforms and integrated contract development and manufacturing organization (CDMO) services. This strategy aims to accelerate the development of cell and gene therapies, enhance scalability, and ensure regulatory compliance. Integrated CDMO services provide comprehensive solutions by combining product development, process optimization, and large-scale manufacturing within a single provider, helping to streamline biopharmaceutical production and speed up market entry. For example, in October 2025, AGC Biologics, a US-based biopharmaceutical contract manufacturer, launched a dedicated Cell and Gene Therapy Business Division. This initiative was designed to strengthen its end-to-end capabilities in the development and manufacturing of plasmid DNA, viral vectors, and cell therapies. The division focuses on improving production efficiency, optimizing processes, and delivering customized solutions that support a faster transition from clinical development to commercial-scale manufacturing. By integrating expertise across multiple platforms, this approach fosters innovation in gene transfer technologies, accelerates therapeutic timelines, and advances the global cell and gene therapy sector.

Who Are The Dominant Players Shaping The Gene Transfer Technologies Market Landscape?

Major companies operating in the gene transfer technologies market are Thermo Fisher Scientific, Merck KGaA, Evonik Industries, Lonza Group AG, Agilent Technologies Inc., Charles River Laboratories, Sartorius AG, Bio-Techne Corporation, Takara Bio Inc., Aldevron, Regenxbio Inc., CureVac AG, OriGene Technologies, Precision NanoSystems, 4D Molecular Therapeutics, Synthego Corporation, Addgene, Acuitas Therapeutics, Transposagen Biopharmaceuticals, Vigene Biosciences.

Read the full gene transfer technologies market report here:

https://www.thebusinessresearchcompany.com/report/global-gene-transfer-technologies-market-report

Which Region Is Forecast To Lead The Gene Transfer Technologies Market In Terms Of Market Size?

North America was the largest region in the gene transfer technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene transfer technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gene Transfer Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30288&type=smp

Browse Through More Reports Similar to the Global Gene Transfer Technologies Market 2026, By The Business Research Company

Nitrobenzene Global Market Report

https://www.thebusinessresearchcompany.com/report/nitrobenzene-global-market-report

Triazole Fungicides Global Market Report

https://www.thebusinessresearchcompany.com/report/triazole-fungicides-global-market-report

Ranibizumab Global Market Report

https://www.thebusinessresearchcompany.com/report/ranibizumab-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795